Optimizing LBP & FMT Commercialization Models to Identifying Sustainable Microbiome Growth Strategies

• Evaluating consumer commercialization approaches to identifying scalable market adoption strategies for LBP & FMT developers
• Assessing reimbursement-driven therapeutic models to determining long-term revenue generation opportunities across microbiome markets
• Identifying customer engagement techniques to strengthening awareness, retention & downstream therapeutic demand

Speakers:

Bernat Olle

Chief Executive Officer

Vedanta Biosciences

Giana Jarrah

Founder & Chief Executive Officer

With Meraki Co.

Bharat Dixit

Chief Technology Officer

Adiso Therapeutics

Momo Vuyisich

Founding Chief Science Officer and Head of Clinical Research

Viome

Todd Krueger

Chief Executive Officer

AOBiome